Organon's hormone-free IUD shows efficacy through 6 years in trial

October 16, 2026 7:30 AM

Organon (NYSE: OGN) announced that Sebela Women's Health will present interim Phase 3 results for MIUDELLA, a hormone-free copper intrauterine ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found